“…Furthermore, quantitation of metabolites, which concentration varies as a consequence of the disease, is important to identify new biomarkers [21]. The 'omics' may help to identify these changes in metabolism or signaling and the results could be integrated to get more information, since there are metabolites, genes, and proteins that are constantly interacting and that may be responsible for the disease pathophysiology [22]. Nevertheless, it is necessary to use computational tools to manipulate and integrated this data, such as Archimedes for diabetes [23], diverse signaling and metabolic networks stored at Biomodels, the network-based drug-repositioning PROMISCUOUS a database for; [24], or enhanced pharmacodynamics models [25], among others.…”